|
|
News Breaks
|
December 21, 2011
|
| 10:39 EDT |  | AIRM, TMH, TMH, TMH, MD, MD, MD, LIFE, LIFE, LIFE, LH, LH, LH, IPCM, IPCM, IPCM, ILMN, ILMN, ILMN, HOLX, HOLX, HOLX, GPRO, GPRO, GPRO, GHDX, GHDX, GHDX, DGX, DGX, DGX, CPHD, CPHD, CPHD, BDX, BDX, BDX, ALR, ALR, ALR, WAT, WAT, WAT |
| theflyonthewall.com: | RBC Capital's healthcare analysts holds a conference call | | Healthcare Diagnostics & Labs Analyst Bonello, along with Healthcare Services Morgan, provide a preview of their top picks for 2012 on an Analyst/Industry conference call. Covered companies AIRM, ALR, BDX, CPHD, DGX, GHDX, GPRO, HOLX, ILMN, IPCM, LH, LIFE, MD, TMH and WAT may be discussed on the Analyst/Industry conference call to be held on January 6 at 10:30 am hosted by RBC Capital. :theflyonthewall.com |
|
|
News For AIRM;ALR;BDX;CPHD;DGX;GHDX;GPRO;HOLX;ILMN;IPCM;LH;LIFE;MD;TMH;WAT From The Last 14 Days Check below for free stories on AIRM;ALR;BDX;CPHD;DGX;GHDX;GPRO;HOLX;ILMN;IPCM;LH;LIFE;MD;TMH;WAT the last two weeks.
There are 40 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 23, 2012
|
| 11:45 EDT |  | ALR |
| | 11:32 EDT |  | ALR |
| theflyonthewall.com: | Alere downgraded to Hold from Buy at Capstone | | :theflyonthewall.com |
| | 07:34 EDT | | LH |
| theflyonthewall.com: | LabCorp and XDx sign collaboration and license agreement on lupus predictor test | | LabCorp has entered into a collaboration and license agreement with XDx whereby each party will collaborate in marker discovery, and LabCorp will develop and commercialize a diagnostic test to predict flares of systemic lupus erythematosus. The agreement combines XDx’s autoimmune diagnostics research and discovery experience and SLE blood sample database with LabCorp’s diagnostic development and commercialization resources. Financial terms of the agreement were not disclosed. :theflyonthewall.com |
| | 07:02 EDT | | CPHD |
|
|
May 22, 2012
|
| 13:36 EDT | | BDX |
| theflyonthewall.com: | Becton Dickinson appoints CEO Vincent Forlenza as chairman of the board | | Forlenza will succeed Edward Ludwig, who is retiring from the company. :theflyonthewall.com |
| | 07:45 EDT |  | GHDX |
| theflyonthewall.com: | Genomic Health target raised to $43 from $33 at JMP Securities | | After conducting due diligence with oncology surgeons, JMP Securities believes that Genomic's DCIS test could potentially generate a large amount of revenue. The firm reiterates an Outperform rating. :theflyonthewall.com |
| | 07:35 EDT | | GPRO |
|
|
May 21, 2012
|
| 10:34 EDT |  | WAT |
| theflyonthewall.com: | On The Fly: Analyst Upgrade Summary | | Today's noteworthy upgrades include: Alpha Natural (ANR) upgraded to Buy from Hold at Brean Murray... American Eagle (AEO) upgraded to Buy from Hold at Brean Murray... Group 1 Automotive (GPI) upgraded to Buy from Neutral at Sterne Agee... LPL Investment (LPLA) upgraded to Neutral from Negative at Susquehanna... Mid-Con Energy (MCEP) upgraded to Outperform from Market Perform at Raymond James... Safeway (SWY) upgraded to Buy from Neutral at Citigroup... United Bankshares (UBSI) upgraded to Buy from Neutral at Janney Capital... Waters (WAT) upgraded to Buy from Neutral at Mizuho... Boeing (BA) upgraded to Buy from Hold at Argus. :theflyonthewall.com |
| | 07:25 EDT | | LIFE |
| theflyonthewall.com: | Life Technologies shares undervalued, says Oppenheimer | | After meeting with Life's management, Oppenheimer believes that investors' concerns that the company will abandon its share buyback plans are unwarranted. The firm reiterates a $58 target and Outperform rating on the stock. :theflyonthewall.com |
| | 05:34 EDT | | WAT |
|
|
May 18, 2012
|
| 09:31 EDT | | LH, DGX |
| | 08:14 EDT | | HOLX |
|
|
May 17, 2012
|
| 15:31 EDT | | DGX |
| | 10:33 EDT |  | WAT |
| theflyonthewall.com: | On The Fly: Analyst Initiation Summary | | Today's noteworthy initiations include: Agilent (A) initiated with an Outperform at Wells Fargo... Alphatec (ATEC) initiated with an Overweight at Piper Jaffray... ArthroCare (ARTC) initiated with an Overweight at Piper Jaffray... Bruker (BRKR) initiated with an Outperform at Wells Fargo... CareFusion (CFN) initiated with an Overweight at Piper Jaffray... Celadon Group (CGI) initiated with a Buy at Wunderlich... Crocs (CROX) initiated with a Neutral at SunTrust... Infoblox (BLOX) initiated with an Outperform at JMP Securities... Kirby (KEX) initiated with a Buy at Wunderlich... Knight Transportation (KNX) initiated with a Buy at Wunderlich... Micron (MU) initiated with a Neutral at Susquehanna... Rush Enterprises (RUSHA) initiated with a Buy at Wunderlich... SanDisk (SNDK) initiated with a Positive at Susquehanna... Swift Transportation (SWFT) initiated with a Buy at Wunderlich... Thermo Fisher (TMO) initiated with a Market Perform at Wells Fargo... Tyler Technologies (TYL) initiated with a Buy at Benchmark Co... Waters (WAT) initiated with an Outperform at Wells Fargo... Werner (WERN) initiated with a Buy at Wunderlich... US Airways (LCC) initiated with an Outperform at Raymond James. :theflyonthewall.com |
| | 09:20 EDT | | CPHD |
| | 06:43 EDT | | WAT |
| theflyonthewall.com: | Waters initiated with an Outperform at Wells Fargo | | Price target range $98-$103. :theflyonthewall.com |
|
|
May 15, 2012
|
| 10:14 EDT | | LIFE |
| | 10:14 EDT | | CPHD |
| theflyonthewall.com: | On The Fly: Analyst Upgrade Summary | | Today's noteworthy upgrades include: Akamai (AKAM) upgraded to Buy from Neutral at Janney Capital... Amazon.com (AMZN) upgraded to Outperform from Neutral at Credit Suisse... Amedisys (AMED) upgraded to Outperform from Neutral at RW Baird... Cepheid (CPHD) upgraded to Buy from Neutral at UBS... Dominion (D) upgraded to Buy from Hold at Jefferies... Flextronics (FLEX) upgraded to Buy from Neutral at BofA/Merrill... Gentiva Health (GTIV) upgraded to Neutral from Underperform at RW Baird... Jabil Circuit (JBL) upgraded to Buy from Neutral at BofA/Merrill... Juniper (JNPR) upgraded to Buy from Neutral at BofA/Merrill... KiOR (KIOR) upgraded to Buy from Neutral at Citigroup... MIPS Technologies (MIPS) upgraded to Buy from Hold at Benchmark Co... Silver Wheaton (SLW) upgraded to Outperform from Neutral at Macquarie... Southern Company (SO) upgraded to Buy from Hold at Jefferies. :theflyonthewall.com |
| | 06:32 EDT | | CPHD |
| | 06:25 EDT | | LIFE |
|
|
May 14, 2012
|
| 09:08 EDT | | HOLX, GPRO |
| | 07:01 EDT | | HOLX |
| theflyonthewall.com: | Hologic upgraded to Overweight from Neutral at JPMorgan | | JP Morgan upgraded Holgic (HOLX) to reflect compelling risk/reward and synergies from the Gen-Probe (GPRO) deal. Price target raised to $22 from $20. :theflyonthewall.com |
|
|
May 11, 2012
|
| 22:06 EDT | | GHDX |
| | 16:15 EDT |  | ALR |
| theflyonthewall.com: | On The Fly: Closing Wrap | | Stocks on Wall Street were mixed, as the Nasdaq was just barely able to cling to a marginal gain for the session. Stock futures pointed to a sharply lower open following JPMorgan’s (JPM) announcement of a $2B trading loss. The futures moved off their lows prior to the open but the broader market opened in negative territory. The averages found a level where they began to build following the highest consumer confidence reading since January 2008. Each of the major indices made it to positive territory and then went into a slow drift lower, with only the Nasdaq avoiding a return to the red... ECONOMIC EVENTS: Domestically, the producer price index report showed that prices fell 0.2% in April, versus expectations for no change. The core reading, which strips out food and energy, rose 0.2%, which was in line with expectations. The University of Michigan Consumer Confidence reading was 77.8, stronger than the expected 76 reading and its highest level since January 2008. Internationally, data from China and India may signal a further weakening of the global recovery, as China reported its industrial production rose 9.3% from a year ago in April while India's industrial output fell 3.5% in March from the prior year... COMPANY NEWS: The surprising announcement from JPMorgan of a $2B trading loss at one of its divisions triggered calls for tougher bank regulation and a sell off in its shares. CEO Jamie Dimon admitted to “egregious” failures in its risk management and said the losses could deepen this quarter and beyond, sending its stock down more than 9%... MAJOR MOVERS: Among the notable gainers were Arena Pharmaceuticals (ARNA), up $2.70, or 73.77%, to $6.36, after an FDA panel backed the approval of its weight loss drug, lorcaserin, and Monster Worldwide (MWW), up $1.50, or 19.13%, to $9.33, after Reuters said the company has attracted takeover interest from LinkedIn (LNKD) and Silver Lake, but CNNMoney said sources close to LinkedIn denied that report. Noteworthy losers included Alere (ALR), down $3.28, or 14.71%, to $19.02, following its disclosure of a subpoena from the Department of Health and Human Services and the potential of broader recalls of certain products after an FDA inspection, and Chesapeake Energy (CHK), down $2.37, or 13.80%, to $14.81, after the company said it would need to delay its 10-Q filing and then made the filing shortly afterward, in which it said it may have to delay some of its asset sales... INDICES: The Dow lost 34.44, or 0.27%, to 12,820.60; the Nasdaq rose 0.18, or 0.01%, to 2,933.82; and the S&P 500 dropped 4.60, or 0.34%, to 1,353.39. :theflyonthewall.com |
| | 12:42 EDT | | ALR |
| | 12:00 EDT |  | ALR |
| | 10:24 EDT | | ALR |
| | 10:21 EDT | | ALR |
| | 10:00 EDT | | ALR |
| | 09:44 EDT | | ALR |
| theflyonthewall.com: | Alere gaps down sharply, support is at $18.77 | | :theflyonthewall.com |
| | 09:33 EDT | | WAT |
| | 09:00 EDT | | ALR |
| | 06:31 EDT | | ALR |
|
|
May 10, 2012
|
| 16:25 EDT | | ALR |
| | 16:25 EDT | | ALR |
| | 16:23 EDT | | ALR |
| | 16:22 EDT | | ALR |
|
|
May 9, 2012
|
| 13:06 EDT | | MD |
| | 11:54 EDT | | MD |
| theflyonthewall.com: | MEDNAX trades higher after CMS proposes Medicaid payments rule | | MEDNAX shares are trading high after the Centers for Medicare & Medicaid Services, or CMS, provided a link to an unpublished proposed rule relating to Medicaid payments for services. The rule states that Medicaid payment for primary care services in 2013 and 2014 will be rates not less than the Medicare rates in effect in those years or, if greater, the payment rates that would be applicable in those years using the 2009 Medicare physician fee schedule conversion factor. The rule also provides that services provided by subspecialists related to the primary care specialists designated in the statute would also qualify for higher payment. Shares are MEDNAX are currently up 7%, or $4.35, to $49.46. :theflyonthewall.com |
| | 11:37 EDT | | MD |
|
|
|
|
|
Subscribe for More Information